Maison Capital

Total investments

38

Average round size

23M

Portfolio companies

33

Rounds per year

1.90

Lead investments

7

Follow on index

0.13

Exits

3

Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceFood and BeverageHealth CareRoboticsManufacturingMedicalElectronics

Summary

In 2004 was created Maison Capital, which is appeared as VC. The main office of represented VC is situated in the Grand Cayman. The fund was located in North America if to be more exact in Cayman Islands.

For fund there is no match between the location of its establishment and the land of its numerous investments - China. We can highlight the next thriving fund investment areas, such as Food Delivery, 3D Technology. Among the most popular portfolio startups of the fund, we may highlight NASN Automotive Electronics, iXiandou, SinoUnited Health Clinic. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

The important activity for fund was in 2019. Considering the real fund results, this VC is 34 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year.

Besides them, we counted 8 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Maison Capital, startups are often financed by ZhenFund, Qiming Venture Partners, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are Qiming Venture Partners, Seas Capital, Matrix Partners China. In the next rounds fund is usually obtained by Qiming Venture Partners, Yunyi Capital, U.S.-China Green Fund.

Show more

Investments analytics

Analytics

Total investments
38
Lead investments
7
Exits
3
Rounds per year
1.90
Follow on index
0.13
Investments by industry
  • Health Care (9)
  • Biotechnology (6)
  • Artificial Intelligence (6)
  • Medical (5)
  • Electronics (5)
  • Show 54 more
Investments by region
  • China (34)
  • France (1)
  • United States (3)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
38M
Group Appearance index
0.76
Avg. company exit year
7
Avg. multiplicator
2.38

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Health Biotech 11 Oct 2017 Biotechnology, Medical Device, Medical Seed 463K Beijing, Changping, China
PatientFi 20 Feb 2024 Financial Services, FinTech, Finance, Health Care Early Stage Venture 25M United States, California, Irvine
SFMAP Technology 27 Mar 2020 Early Stage Venture 14M Guangdong, Dongguang, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.